163 related articles for article (PubMed ID: 36993465)
1. Novel Tools for Lassa Virus Surveillance in Peri-domestic Rodents.
Smither AR; Koninga J; Kanneh FB; Foday M; Boisen ML; Bond NG; Momoh M; Sandi JD; Kanneh L; Alhasan F; Kanneh IM; Yillah MS; Grant DS; Bush DJ; Nelson DKS; Cruz KM; Klitting R; Pauthner M; Andersen KG; Shaffer JG; Cross RW; Schieffelin JS; Garry RF
medRxiv; 2023 Mar; ():. PubMed ID: 36993465
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study.
Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101
[TBL] [Abstract][Full Text] [Related]
3. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
[TBL] [Abstract][Full Text] [Related]
4. Lassa Virus Circulation in Small Mammal Populations in Bo District, Sierra Leone.
Bangura U; Buanie J; Lamin J; Davis C; Bongo GN; Dawson M; Ansumana R; Sondufu D; Thomson EC; Sahr F; Fichet-Calvet E
Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33466234
[TBL] [Abstract][Full Text] [Related]
5. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
[TBL] [Abstract][Full Text] [Related]
6. Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria.
Ogunro BN; Olugasa BO; Kayode A; Ishola OO; Kolawole ON; Odigie EA; Happi C
J Epidemiol Glob Health; 2019 Jun; 9(2):125-127. PubMed ID: 31241870
[TBL] [Abstract][Full Text] [Related]
7. Lassa fever in post-conflict sierra leone.
Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
[TBL] [Abstract][Full Text] [Related]
8. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK;
PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258
[TBL] [Abstract][Full Text] [Related]
9. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.
Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF
Virol J; 2011 Aug; 8():404. PubMed ID: 21843352
[TBL] [Abstract][Full Text] [Related]
10. Multiple circulating infections can mimic the early stages of viral hemorrhagic fevers and possible human exposure to filoviruses in Sierra Leone prior to the 2014 outbreak.
Boisen ML; Schieffelin JS; Goba A; Oottamasathien D; Jones AB; Shaffer JG; Hastie KM; Hartnett JN; Momoh M; Fullah M; Gabiki M; Safa S; Zandonatti M; Fusco M; Bornholdt Z; Abelson D; Gire SK; Andersen KG; Tariyal R; Stremlau M; Cross RW; Geisbert JB; Pitts KR; Geisbert TW; Kulakoski P; Wilson RB; Henderson L; Sabeti PC; Grant DS; Garry RF; Saphire EO; Branco LM; Khan SH;
Viral Immunol; 2015 Feb; 28(1):19-31. PubMed ID: 25531344
[TBL] [Abstract][Full Text] [Related]
11. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
[TBL] [Abstract][Full Text] [Related]
12. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future Perspectives.
Aloke C; Obasi NA; Aja PM; Emelike CU; Egwu CO; Jeje O; Edeogu CO; Onisuru OO; Orji OU; Achilonu I
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680186
[TBL] [Abstract][Full Text] [Related]
13. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever.
Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF
Virol J; 2010 Oct; 7():279. PubMed ID: 20961433
[TBL] [Abstract][Full Text] [Related]
14. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
[TBL] [Abstract][Full Text] [Related]
15. Sequence variability and geographic distribution of Lassa virus, Sierra Leone.
Leski TA; Stockelman MG; Moses LM; Park M; Stenger DA; Ansumana R; Bausch DG; Lin B
Emerg Infect Dis; 2015 Apr; 21(4):609-18. PubMed ID: 25811712
[TBL] [Abstract][Full Text] [Related]
16. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions.
Arruda LB; Free HB; Simons D; Ansumana R; Elton L; Haider N; Honeyborne I; Asogun D; McHugh TD; Ntoumi F; Zumla A; Kock R
PLOS Glob Public Health; 2023; 3(11):e0002159. PubMed ID: 37939051
[TBL] [Abstract][Full Text] [Related]
17. Undiagnosed acute viral febrile illnesses, Sierra Leone.
Schoepp RJ; Rossi CA; Khan SH; Goba A; Fair JN
Emerg Infect Dis; 2014 Jul; 20(7):1176-82. PubMed ID: 24959946
[TBL] [Abstract][Full Text] [Related]
18. Identification of Common CD8
Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
[TBL] [Abstract][Full Text] [Related]
19. Detection of Lassa Virus-Reactive IgG Antibodies in Wild Rodents: Validation of a Capture Enzyme-Linked Immunological Assay.
Soubrier H; Bangura U; Hoffmann C; Olayemi A; Adesina AS; Günther S; Oestereich L; Fichet-Calvet E
Viruses; 2022 May; 14(5):. PubMed ID: 35632733
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
